News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,483 Results
Type
Article (40646)
Company Profile (253)
Press Release (661584)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (204895)
Career Advice (2058)
Deals (35569)
Drug Delivery (96)
Drug Development (81349)
Employer Resources (172)
FDA (16276)
Job Trends (14963)
News (346509)
Policy (32701)
Tag
Academia (2576)
Accelerated approval (6)
Adcomms (21)
Allergies (85)
Alliances (49666)
ALS (90)
Alzheimer's disease (1379)
Antibody-drug conjugate (ADC) (124)
Approvals (16277)
Artificial intelligence (256)
Autoimmune disease (21)
Automation (16)
Bankruptcy (362)
Best Places to Work (11695)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (180)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (280)
Cancer (2262)
Cardiovascular disease (175)
Career advice (1720)
Career pathing (30)
CAR-T (151)
Cell therapy (423)
Cervical cancer (19)
Clinical research (66193)
Collaboration (837)
Compensation (527)
Complete response letters (21)
COVID-19 (2597)
CRISPR (40)
C-suite (244)
Cystic fibrosis (100)
Data (2202)
Decentralized trials (2)
Denatured (18)
Depression (44)
Diabetes (275)
Diagnostics (6427)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86759)
Editorial (36)
Employer branding (21)
Employer resources (146)
Events (113096)
Executive appointments (729)
FDA (17528)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (753)
Gene editing (105)
Generative AI (20)
Gene therapy (302)
GLP-1 (708)
Government (4445)
Grass and pollen (4)
Guidances (59)
Healthcare (18913)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (29)
Infectious disease (2740)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (96)
Interviews (325)
IPO (16554)
IRA (41)
Job creations (3688)
Job search strategy (1459)
Kidney cancer (10)
Labor market (38)
Layoffs (478)
Leadership (17)
Legal (7947)
Liver cancer (75)
Lung cancer (321)
Lymphoma (153)
Machine learning (7)
Management (58)
Manufacturing (303)
MASH (66)
Medical device (13459)
Medtech (13464)
Mergers & acquisitions (19558)
Metabolic disorders (687)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1919)
NextGen: Class of 2025 (6577)
Non-profit (4499)
Now hiring (39)
Obesity (362)
Opinion (207)
Ovarian cancer (75)
Pain (86)
Pancreatic cancer (84)
Parkinson's disease (149)
Partnered (21)
Patents (234)
Patient recruitment (112)
Peanut (46)
People (57526)
Pharmaceutical (63)
Pharmacy benefit managers (19)
Phase I (20657)
Phase II (29161)
Phase III (21717)
Pipeline (1191)
Policy (140)
Postmarket research (2569)
Preclinical (8776)
Press Release (65)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (248)
Rare diseases (384)
Real estate (5948)
Recruiting (65)
Regulatory (22380)
Reports (46)
Research institute (2334)
Resumes & cover letters (354)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (130)
Series B (85)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3611)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (39)
The Weekly (31)
Vaccines (689)
Venture capitalists (41)
Weight loss (234)
Women's health (35)
Worklife (17)
Date
Today (165)
Last 7 days (857)
Last 30 days (2635)
Last 365 days (33137)
2025 (10705)
2024 (35541)
2023 (40271)
2022 (51357)
2021 (55885)
2020 (54263)
2019 (46798)
2018 (35191)
2017 (32505)
2016 (31787)
2015 (37747)
2014 (31468)
2013 (26509)
2012 (28716)
2011 (29408)
2010 (27464)
Location
Africa (732)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (38146)
Australia (6227)
California (6137)
Canada (2013)
China (521)
Colorado (269)
Connecticut (284)
Delaware (146)
Europe (82142)
Florida (909)
Georgia (206)
Idaho (58)
Illinois (546)
India (25)
Indiana (308)
Iowa (11)
Japan (161)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (898)
Massachusetts (4612)
Michigan (219)
Minnesota (394)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1751)
New Mexico (28)
New York (1741)
North Carolina (990)
North Dakota (8)
Northern California (2674)
Ohio (203)
Oklahoma (14)
Oregon (34)
Pennsylvania (1380)
Puerto Rico (12)
Rhode Island (33)
South America (1119)
South Carolina (22)
South Dakota (1)
Southern California (2310)
Tennessee (101)
Texas (908)
United States (23247)
Utah (181)
Virginia (146)
Washington D.C. (61)
Washington State (552)
West Virginia (3)
Wisconsin (60)
702,483 Results for "x therma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
X-Therma Achieves GMP Commercial Readiness with XT-Thrive®
X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has achieved GMP commercial readiness with its flagship product, XT-Thrive®.
May 29, 2024
·
3 min read
Press Releases
Therma Bright Reviews Manufacturing Strategy in Light of US Tariff Changes
April 16, 2025
·
4 min read
Press Releases
Therma Bright Secures New Customer Initial Purchase Order, Signaling Market Confidence
April 24, 2025
·
4 min read
Biotech Bay
X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)
X-Therma Inc , announces that the Food and Drug Administration (FDA) accepted a Drug Master File (DMF) covering its product, XT-Thrive ® .
April 17, 2024
·
2 min read
Biotech Bay
X-Therma’s $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation
X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has completed an oversubscribed $22.4 million Series B funding round.
March 13, 2024
·
5 min read
Therma Bright Completes Debt Settlements
Toronto, Ontario--(Newsfile Corp. - June 19, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma” or the “Company”), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, announces...
June 19, 2024
·
3 min read
Press Releases
Therma Bright Announces Shares for Debt Issuance
January 9, 2025
·
2 min read
Press Releases
Therma Bright Announces Shares for Debt Issuance
January 3, 2025
·
2 min read
Therma Bright Closes Second & Final Tranche of Fully Subscribed Non-Brokered Private Placement
Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma” or the “Company”), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies
June 21, 2024
·
4 min read
Therma Bright Closes $854,500 First Tranche of Non-Brokered Private Placement
Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma” or the “Company”), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies
June 10, 2024
·
5 min read
1 of 70,249
Next
